Illicit drug overdose: managing emergency care With up to 253,000 deaths related to drug misuse globally, understanding how to identify and treat drug overdoses can save lives.…
More than 1 in 10 secondary school children have used e-cigarettes Study reveals that 5.8% of primary school children (10–11 years) and 12.3% of secondary school children (11–16 years) have used e-cigarettes.…
WHO calls for drug development incentives for neglected diseasesIncentives are needed to encourage the development of new medicines to tackle diseases that disproportionately affect the poor, says the World Health Organization.…
Broadly neutralising antibody shows some success in treating patients with HIV A potent type of antibody therapy trialled in HIV patients for the first time has been shown to reduce the amount of virus in patients’ blood.…
Unnecessary visits to A&E will continue to occurI wish to comment on Adam Pattison Rathbone’s blog ‘Could pharmacists be part of the A&E problem?’ ( The Pharmaceutical Journal 2015;294:385). I would like to share a recent experience of mine that illustrates how the pressures on out-of-hour GP services and a…
Placebo effect genes identifiedResearchers have identified at least 11 genes that influence individuals’ susceptibility to the placebo effect.…
Better information is needed to improve palliative care services Gaps in access to palliative care services mean that many patients with life-limiting illnesses miss out on support they need, but there is much to learn about people’s experiences at the end of life.…
Small molecule could pave way for novel vaccine adjuvants Identification and characterisation of a small molecule that targets protein receptors that stimulate the immune system could lead to novel vaccine adjuvants and anti-tumour agents.…
Researchers create personalised vaccines for patients with advanced melanoma A study has revealed that targeting patient-specific markers in advanced melanoma tumours effectively triggers an immune response.…
Meta-analysis casts doubt over first-line paracetamol use for back pain and osteoarthritis A meta-analysis published in The BMJ has cast doubt on the use of paracetamol as the first-line analgesic for spinal pain and osteoarthritis of the hip and knee.…